Biodesix shareholders elect three Class I directors and approve all proposals at 2024 annual meeting

BIODESIX INC

Jon Faiz Kayyem, Scott Hutton, and John Patience elected as Class I directors with over 79M votes each.
Ratification of KPMG as independent auditor for FY2024 approved (88.3M for, 167K against).
Conversion of Series A Preferred Stock into common stock approved (82.4M for, 5.8K abstain).
Issuance of Series A Preferred Stock to directors/officers approved (82.3M for, 437K against).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.